What are the most valued startups in the digital health market?

Last updated: 13 July 2026

Download our beautiful pitch about the digital health market

market research pitch 2026 statistics digital health market

In our digital health market deck, you will find everything you need to understand the market

The digital health market includes telehealth providers, clinical software platforms, remote monitoring companies, AI healthcare tools and technology-enabled care businesses.

This ranking tracks the most valuable digital health startups using public market capitalizations, funding-round valuations, acquisition prices and carefully calculated estimates.

We update this digital health startup list every month to reflect new funding rounds, public-market movements, acquisitions and operating developments.

And if you want to better understand this new industry, you can download our pitch covering the digital health market.

A quick summary table

Metric Value
Most valuable digital health startup Hims & Hers, $8.1B
Second most valuable digital health startup Hinge Health, $6.9B
Median digital health startup valuation Approximately $400M
Share of digital health valuation captured by the top 10 Approximately 58.8%
Top digital health startup valuation vs. median Approximately 20.3 times
Median digital health valuation-to-capital-raised ratio Approximately 3.4 times
Digital health startups valued at $1B+ 19
Market map chart showing top companies and startups in the digital health market

This market map, featured in our digital health market deck, highlights top companies and startups in the digital health market

Top startups in the digital health market ranked by valuation

Here is an updated table that ranks the top startups in the digital health market based on their latest reported or estimated valuations.

If you want more detaild about their fundraising activity, you can check our list of the startups who have raised the most funding in the digital health market.

# Startup Name What They Do Current Valuation ($) Valuation Confidence Level Valuation Type Evidence Status Total Funding ($) Funding Confidence Level
1 Hims & Hers Consumer telehealth and pharmacy $8.1B Full Confidence Public Market Cap Observed $197M Strong Confidence
2 Hinge Health Digital MSK physical therapy $6.9B Full Confidence Public Market Cap Observed $1.1B Strong Confidence
3 Abridge AI clinical documentation platform $5.0B–$5.8B Strong Confidence Announced Private Round Valuation Estimated $758M Full Confidence
4 Ro Direct-to-patient telehealth platform $4.5B–$6.0B Partial Confidence Comparables-Based Estimate Estimated $1.0B Strong Confidence
5 Sword Health AI virtual MSK care $3.8B–$4.4B Strong Confidence Announced Private Round Valuation Estimated $380M Partial Confidence
6 Aledade Value-based primary care network $3.5B–$4.5B Strong Confidence Revenue or ARR Multiple Estimate Estimated $721M Strong Confidence
7 Innovaccer Healthcare data and AI cloud $3.3B–$3.6B Strong Confidence Announced Private Round Valuation Estimated $675M Strong Confidence
8 Athelas Remote care and billing automation $2.4B Strong Confidence Acquisition Value Observed $136M Partial Confidence
9 Virta Health Diabetes reversal virtual care $2.0B–$2.6B Strong Confidence Revenue or ARR Multiple Estimate Estimated $374M Partial Confidence
10 Included Health Integrated virtual care navigation $1.5B–$2.2B Partial Confidence Revenue or ARR Multiple Estimate Estimated $281M Partial Confidence
11 Cedar Patient billing engagement software $1.5B–$2.2B Partial Confidence Comparables-Based Estimate Estimated $326M Strong Confidence
12 Maven Clinic Women’s family virtual clinic $1.5B–$1.9B Strong Confidence Announced Private Round Valuation Estimated $425M Strong Confidence
13 Omada Health Virtual chronic care programs $1.4B Full Confidence Public Market Cap Observed $450M Strong Confidence
14 Cadence AI chronic care management $1.2B Full Confidence Announced Private Round Valuation Observed $241M Full Confidence
15 Eucalyptus Consumer telehealth brand portfolio $1.2B Strong Confidence Acquisition Value Observed $103M Strong Confidence
16 BioIntelliSense Medical wearable patient monitoring $1.0B–$1.3B Strong Confidence Announced Private Round Valuation Estimated $140M Strong Confidence
17 NexHealth Patient experience API platform $900M–$1.3B Partial Confidence Comparables-Based Estimate Estimated $177M Strong Confidence
18 FIRE1 Heart failure monitoring device $800M–$1.3B Partial Confidence Implied Valuation from Raise Implied $227M Partial Confidence
19 Cerebral Online mental healthcare $800M–$1.2B Partial Confidence Revenue or ARR Multiple Estimate Estimated $462M Full Confidence
20 Twin Health Metabolic digital twin care $950M Strong Confidence Announced Private Round Valuation Observed $286M Strong Confidence
21 Biofourmis Remote monitoring digital therapeutics $750M–$1.1B Partial Confidence Comparables-Based Estimate Estimated $465M Strong Confidence
22 Midi Health Virtual midlife women’s care $700M–$1.0B Strong Confidence Revenue or ARR Multiple Estimate Estimated $149M Full Confidence
23 Huma AI remote patient monitoring $700M–$1.0B Partial Confidence Revenue or ARR Multiple Estimate Estimated $281M Partial Confidence
24 AKASA AI healthcare revenue-cycle automation $700M–$1.0B Partial Confidence Comparables-Based Estimate Estimated $250M Partial Confidence
25 Phreesia Patient intake engagement platform $671M Full Confidence Public Market Cap Observed $276M Partial Confidence
26 Genome Medical Telegenomics care delivery $500M–$750M Partial Confidence Implied Valuation from Raise Implied $181M Partial Confidence
27 Ada Health AI symptom assessment platform $500M–$700M Partial Confidence Announced Private Round Valuation Estimated $167M Full Confidence
28 Wheel Virtual care infrastructure $450M–$700M Low Confidence Implied Valuation from Raise Estimated $216M Full Confidence
29 Suki AI clinical documentation assistant $500M–$650M Strong Confidence Announced Private Round Valuation Estimated $165M Strong Confidence
30 Doctor On Demand On-demand virtual care $400M–$700M Low Confidence Proxy-Based Estimate Estimated $239M Strong Confidence
31 Brightside Health Virtual mental health care $450M–$650M Partial Confidence Announced Private Round Valuation Estimated $111M Strong Confidence
32 Fabric Healthcare access automation $400M–$650M Partial Confidence Implied Valuation from Raise Estimated $80M Full Confidence
33 Lark AI chronic care coaching $400M–$650M Low Confidence Comparables-Based Estimate Estimated $181M Partial Confidence
34 Doctor Anywhere Regional telehealth and clinics $350M–$600M Partial Confidence Implied Valuation from Raise Estimated $176M Strong Confidence
35 InfoBionic Remote cardiac monitoring $350M–$600M Partial Confidence Implied Valuation from Raise Implied $126M Strong Confidence
36 TytoCare Remote medical exam devices $325M–$550M Partial Confidence Implied Valuation from Raise Estimated $205M Strong Confidence
37 Eko Health AI cardiopulmonary detection $325M–$525M Partial Confidence Implied Valuation from Raise Implied $134M Strong Confidence
38 Current Health Remote care management platform $400M Strong Confidence Acquisition Value Observed $66M Strong Confidence
39 SafelyYou AI senior fall detection $300M–$500M Partial Confidence Implied Valuation from Raise Implied $93M Strong Confidence
40 DrFirst E-prescribing workflow software $300M–$430M Partial Confidence Revenue or ARR Multiple Estimate Estimated $165M Partial Confidence
41 Vida Health Virtual cardiometabolic care $250M–$450M Partial Confidence Implied Valuation from Raise Estimated $192M Strong Confidence
42 1upHealth Healthcare data interoperability platform $280M–$420M Partial Confidence Implied Valuation from Raise Implied $75M Strong Confidence
43 Hazel Health School-based pediatric telehealth $275M–$375M Partial Confidence Implied Valuation from Raise Implied $113M Partial Confidence
44 Kyruus Provider search and scheduling $260M–$400M Low Confidence Comparables-Based Estimate Estimated $196M Strong Confidence
45 Avi Medical Hybrid primary care clinics $250M–$375M Low Confidence Implied Valuation from Raise Implied $100M Strong Confidence
46 Healthie API-first digital-health infrastructure $260M–$320M Strong Confidence Proxy-Based Estimate Estimated $39M Strong Confidence
47 Maple Canadian virtual doctor visits $225M–$350M Low Confidence Comparables-Based Estimate Estimated $72M Strong Confidence
48 Accurx Healthcare communication workflow platform $220M–$350M Partial Confidence Implied Valuation from Raise Implied $51M Strong Confidence
49 eVisit Enterprise virtual care platform $200M–$325M Low Confidence Implied Valuation from Raise Implied $70M Strong Confidence
50 CoachCare Remote patient monitoring software $200M–$350M Partial Confidence Implied Valuation from Raise Implied $60M Partial Confidence
51 CareStack Cloud dental practice management $180M–$300M Partial Confidence Comparables-Based Estimate Estimated $67M Partial Confidence
52 Elation Health Primary care EHR software $180M–$270M Partial Confidence Revenue or ARR Multiple Estimate Estimated $109M Strong Confidence
53 Helium Health African healthcare software financing $170M–$260M Partial Confidence Implied Valuation from Raise Implied $42M Strong Confidence
54 Nurx Women’s telehealth and prescriptions $150M–$250M Low Confidence Proxy-Based Estimate Estimated $91M Partial Confidence
55 Vezeeta MENA healthcare booking marketplace $140M–$230M Low Confidence Comparables-Based Estimate Estimated $65M Partial Confidence
56 DrChrono EHR and practice management $180M Strong Confidence Acquisition Value Observed $25M Partial Confidence
57 KeyCare Epic-based virtual care $180M–$280M Partial Confidence Implied Valuation from Raise Implied $54M Partial Confidence
58 Empatica Wearable digital biomarkers $130M–$220M Low Confidence Implied Valuation from Raise Implied $31M Strong Confidence
59 98point6 Virtual care software licensing $120M–$220M Low Confidence Acquisition Value Estimated $305M Partial Confidence
60 Pager Virtual care navigation platform $120M–$220M Low Confidence Revenue or ARR Multiple Estimate Estimated $36M Partial Confidence
61 Amwell Enterprise telehealth platform $144M Full Confidence Public Market Cap Observed $1.7B Partial Confidence
62 Medici Doctor-patient messaging telehealth $100M–$175M Low Confidence Implied Valuation from Raise Implied $70M Strong Confidence
63 Canvas Medical Developer-first electronic health records $90M–$150M Partial Confidence Implied Valuation from Raise Implied $44M Full Confidence
64 Wellframe Digital health-plan member engagement $80M–$140M Low Confidence Acquisition Value Estimated $45M Strong Confidence
65 HealthTap Virtual primary care platform $75M–$125M Low Confidence Comparables-Based Estimate Estimated $38M Full Confidence
66 Practice Fusion Cloud electronic health records $100M Full Confidence Acquisition Value Observed $255M Partial Confidence
67 CareCloud Practice management and billing software $97M Full Confidence Public Market Cap Observed $94M Partial Confidence
68 Dozee Contactless hospital patient monitoring $80M–$110M Partial Confidence Implied Valuation from Raise Implied $33M Partial Confidence
69 Validic Connected health data platform $55M–$90M Low Confidence Comparables-Based Estimate Estimated $32M Strong Confidence
70 Welkin Health Patient relationship management software $45M–$80M Low Confidence Proxy-Based Estimate Estimated $30M Strong Confidence
71 Particle Health Health data exchange API $50M–$70M Partial Confidence Proxy-Based Estimate Estimated $39M Full Confidence
72 Neteera Contactless vital-sign monitoring $40M–$65M Low Confidence Implied Valuation from Raise Implied $22M Strong Confidence
73 Lumeon Automated healthcare care orchestration $40M–$65M Strong Confidence Acquisition Value Observed $83M Partial Confidence
74 Memora Health AI-enabled patient care navigation $25M–$35M Partial Confidence Acquisition Value Estimated $81M Partial Confidence
75 Cloud DX Remote patient monitoring devices $0M–$2M Low Confidence Proxy-Based Estimate Estimated $9M Low Confidence
Chart comparing the 2026 size of the digital health market with other markets of similar size

This chart, featured in our digital health market deck, compares the 2026 size of the digital health market with other markets of similar size

Key valuation trends in the digital health market

Insights

  • The ten largest digital health companies represent about $43.8B, or 58.8% of the combined valuation in this ranking, showing that market value remains concentrated among a small group of category leaders.
  • Hims & Hers has a valuation equal to roughly 41 times its recorded funding, making the consumer telehealth company one of the most capital-efficient businesses in the digital health market.
  • Abridge and Suki have a combined midpoint valuation of almost $6.0B after raising $923M, highlighting the valuation premium attached to AI tools integrated directly into clinical workflows.
  • Aledade, Omada Health, Cadence and Twin Health represent approximately $7.6B in combined value, confirming that reimbursable and longitudinal chronic-care models remain a major digital health category.
  • Eucalyptus, BioIntelliSense and Cadence raised a combined $484M but represent approximately $3.6B in value, producing a valuation-to-funding ratio of about 7.4 times.
  • Hims & Hers, Hinge Health and Omada Health represent $16.4B in public-market value, concentrating observable digital health outcomes in consumer care, musculoskeletal treatment and chronic-disease management.
  • The leading digital health startup is valued at roughly 20 times the median company, while the top ten capture almost three-fifths of total value, revealing a pronounced gap between leaders and smaller platforms.
Chart showing how Hinge Health captured share in the digital health market

This chart, featured in our digital health market deck, shows how Hinge Health captured share in digital health

A few word about our methodology

As you can see, we built a database that ranks startups in the digital health market based on their current valuation.

Estimating digital health startup valuations is not always straightforward. Many companies do not publicly disclose their valuation, and the available information can vary widely depending on the company and its stage.

To build this digital health ranking, we applied a structured valuation methodology and cross-checked information across multiple reliable sources.

Whenever possible, we relied on direct disclosures. These include announced valuations from completed funding rounds, public filings for listed digital health companies, or official acquisition prices.

When a digital health company is publicly listed, we use its current market capitalization as the reference valuation.

If a digital health startup was acquired and no independent valuation can reasonably be estimated today, we use the acquisition price as the main reference point.

When a digital health startup recently raised capital but the valuation was not disclosed, we estimate the implied valuation using typical dilution levels for that stage of fundraising.

In some cases, we also estimate valuations using operating metrics such as revenue, ARR, covered members, patient volumes or customer traction, combined with valuation multiples from comparable digital health companies.

When direct financial data is not available, we may rely on carefully selected comparable startups and other signals such as hiring growth, investor quality, reimbursement coverage, health-system partnerships or product traction.

All estimates follow a strict evidence hierarchy. Recent funding rounds with announced valuations carry the most weight, followed by strong operating metrics and comparable company analysis.

We also carefully evaluate the age of every data point. Recent information carries more weight, while older data is treated cautiously and adjusted conservatively when necessary.

Whenever information is uncertain or incomplete, we clearly distinguish between confirmed facts and reasonable inferences.

Because valuation data is not always fully public, each digital health startup in the ranking is assigned a confidence level based on the reliability, recency and consistency of the available evidence.

Full confidence means the valuation is supported by strong and recent evidence. Strong confidence means the estimate is well supported but includes minor inference. Partial confidence means the estimate relies more heavily on indirect signals. Low confidence means available information is limited or inconsistent.

When confidence is lower, we take a more conservative approach by widening the valuation range. This helps reflect the uncertainty and increases the probability that the true valuation falls within the estimated range.

This reflects how we conduct all our research, including the work behind our report covering the digital health market.

In a world where LLMs hallucinate and unreliable information is everywhere, our goal is simple: provide data you can trust.

If you want the full detail on a specific valuation estimate, feel free to contact us and we will gladly explain.

Finally, know that we update the dataset once per month, so come back here if you need fresh information.

Chart showing the projected CAGR of the digital health market

This chart, featured in our digital health market deck, shows annual funding in digital health startups

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living “market pitch” documents for emerging markets: from AI to synthetic biology and new proteins. Instead of digging through outdated PDFs, random blog posts, and hallucinated LLM answers, our clients get a clean, visual, always-updated view of what’s really happening. We map the key players, deals, regulations, metrics and signals that matter so you can decide faster whether a market is worth your time. Want to know more? Check out our about page. You can also follow us on Instagram or on Facebook.

How we created this content 🔎📝

At New Market Pitch, we kept seeing the same problem: when you look at a new market, the data is either missing, paywalled, or buried in 300-page reports that feel like they were written in the 80s. On the other side, LLMs and random blog posts give you confident answers with no sources, and sometimes they just make things up. That’s not good enough when you’re about to invest real money or launch a company.

So we decided to fix the experience. For each market we cover, we build a structured database and update it on a regular basis. We track funding rounds, fund memos, M&A moves, partnerships, new products, policy changes, and the real activity of startups and incumbents. Then we turn all of that into a clear “market pitch” that shows where the opportunities are and how people actually win in that space.

Every key data point is checked, sourced, and put back into context by our team. That’s how we can give you both speed and reliability: fast coverage of new markets, without the usual guesswork.

Back to blog